| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |